http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02100443-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffe9275b65f232510cbba301787e6635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7621033d9aeb3acf145562e51bc98da2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0017
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
filingDate 2002-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36ea9ca1cc9d1c733f4dd0c56a3b8863
publicationDate 2003-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-02100443-A3
titleOfInvention Identifying tissue within the body using a fluorescent dye
abstract A method and apparatus are disclosed for localizing or identifying specific tissue within the body, such as lymphatic tissue, using a fluorescent dye. A fluorescent dye such as fluorescein sodium or indocyanine green ('ICG') dye is injected into the body adjacent a diseased tissue site, e.g., a cancer site. Preferably, the dye is injected at multiple locations about the periphery of a cancerous lesion. Alternatively, the dye can be injected into the body at any site that will deliver the fluorescent dye to the lymphatic basin associated with the lesion. After injection, the fluorescent dye will enter the lymphatic system associated with the area of cancer. The lymphatic system can be visually identified using a fluorescence detector. The fluorescence detector preferably includes a light source having the particular wavelength of light necessary to create excitation of the fluorescent dye. The fluorescence detector may also include a viewing filter for allowing direct visualization of the fluorescent light emission, while blocking the light emitted by the light source. A fiber-optic light guide may be provided to carry light from the light source to the area of interest. In one preferred method, the sentinel node (the first node in a lymphatic node cluster) is identified using a fluorescent dye by visually tracing the lymphatic system from the injection site to the regional lymph nodes.
priorityDate 2001-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02088666-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02074171-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0021576-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9885981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45157623
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412551
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282412

Total number of triples: 21.